- All
- Canadian News
- Global News
Product Launch – Septra® Pediatric Oral Suspension
Dear Valued Customer, Aspen Pharmacare Canada is excited to announce the launch of Septra® Pediatric Oral Suspension, further expanding our commitment to providing trusted treatment options for Canadian patients and healthcare professionals. ASPEN # BRAND NAME UPC CODE DIN GENERIC NAME STRENGTH PACK SIZE UNIT 7058333 Septra® Pediatric Oral Suspension 678045000899 02563495 Sulfamethoxazole and Trimethoprim
Aspen Pharmacare Canada receives Health Canada approval for a generic equivalent of Ozempic®
New generic equivalent of Ozempic® expected to help expand access to semaglutide treatment options for adults with type 2 diabetes in Canada Oakville, ON — July 21, 2026 — Aspen Pharmacare Canada Inc., a subsidiary of Aspen Pharmacare Holdings Limited (“Aspen”), today announced that Health Canada has approved ᴾʳAspen-Semaglutide, a generic equivalent of Ozempic® (semaglutide
Important Safety Information on Importation of Danish-authorized Marcain–Adrenalin, 5 mg/mL and 5 mcg/mL due to the Current Shortage of Canadian-authorized SENSORCAINE with Epinephrine, 5 mg/mL and 5 mcg/mL
Important Safety Information on Importation of Danish-authorized Marcain–Adrenalin, 5 mg/mL and 5 mcg/mL due to the Current Shortage of Canadian-authorized SENSORCAINE with Epinephrine, 5 mg/mL and 5 mcg/mL
ASPEN PHARMACARE CANADA Inc. Launches ASPEN-Dienogest for the Management of Pelvic Pain Associated With Endometriosis
Oakville, ON, April 15, 2020 – Aspen Pharmacare Canada Inc. is proud to launch ASPEN-Dienogest, a generic drug whose bioequivalence to the brand product VISANNE® has been demonstrated the management of pelvic pain associated with endometriosis. ASPEN-Dienogest provides the same efficacy and safety as the brand product, at a lower cost to patients. ASPEN-Dienogest is
Stephen Saad Speaks to CNBC Africa’s Executive Director Bronwyn Nielsen
Stephen Saad speaks to CNBC Africa’s Executive Director Bronwyn Nielsen on the challenges of doing business in the pharmaceutical industry, succession planning, diversification and expansion.
Stavros Nicolau Interviewed for CNN’s Marketplace Africa
Stavros Nicolau interviewed for CNN’s Marketplace Africa.



